Form 4: Maravai LifeSciences General Counsel Sells Shares to Cover Tax Obligations

Kurt Oreshack, General Counsel of Maravai LifeSciences, sold 31,438 shares of Class A Common Stock to cover tax obligations related to vesting restricted stock units.

Summary

• Kurt Oreshack, the General Counsel of Maravai LifeSciences, sold 31,438 shares of Class A Common Stock on January 15, 2025.
• The sale was executed at a price of $4.56 per share.
• This transaction was to cover tax withholding obligations associated with the vesting of restricted stock unit awards.
• Following the transaction, Oreshack directly owns 192,618 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, not indicative of positive or negative sentiment.

Industry Context

This is a routine transaction for company insiders to manage their tax obligations related to equity compensation. It is common for executives to sell shares to cover taxes when restricted stock units vest.

Comparison to Industry Standards

• Similar transactions are common across publicly traded companies, where executives often sell shares to cover tax liabilities arising from vesting equity awards.
• The sale of shares by insiders is a normal part of equity compensation and is not unusual in the biotech and life sciences industry.
• Companies like Moderna, BioNTech, and Regeneron also see similar transactions by their executives.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale for tax purposes.

Key Dates

Keywords

Maravai LifeSciences, MRVI, insider trading, stock sale, Form 4, Kurt Oreshack, tax obligations, restricted stock units, Class A Common Stock